The program, part of Operation TrialBlazer, aims to speed early research and help the U.S. bring trials back from overseas.

Alveus, Lilly, Viking and Amgen are testing maintenance strategies as durability becomes a bigger focus in obesity R&D.

Dr. John Tsai grabbed the reins of global R&D this year with a clear mandate: extend Daiichi’s oncology momentum beyond its ...

The pharma and biotech industries are constantly in flux. Every year, pharma professionals converge on a number of large ...

Roche announced it's building autonomous AI-powered labs; how a clinical hold on an epilepsy trial could impact Biohaven ...

Companies including GSK, Merck, Roche and Sanofi are pushing new approaches in cancer and inflammatory diseases.

Patients in psychedelic trials often know if they’re taking the study drug or a placebo. But trial design changes could ...

An AI chemistry agent asked a fairly ordinary question: Did a particular molecule have a known hepatobiliary side effect? The agent chose a relevant tool to look for the answer. Then it fed the tool a ...